Literature DB >> 26952832

Frequency of psychiatric disorders in blepharospasm does not differ from hemifacial spasm.

Fernando Machado Dias1, Flávia Doyle2, Arthur Kummer1, Francisco Cardoso2, Leonardo Franklin Fontenelle3, Antonio Lucio Teixeira1.   

Abstract

UNLABELLED: Dias FM, Doyle F, Kummer A, Cardoso F, Fontenelle LF, Teixeira AL. Frequency of psychiatric disorders in blepharospasm does not differ from hemifacial spasm.
OBJECTIVE: To compare the frequency of psychiatric disorders and the severity of psychiatric symptoms between patients with blepharospasm (BS) and hemifacial spasm (HS).
METHODS: BS is a type of primary focal dystonia characterised by recurrent and involuntary eye blinking. HS is a condition with different pathophysiology but similar clinical phenotype. Twenty-two patients with BS and 29 patients with HS participated in this study. They underwent a comprehensive psychiatric evaluation that included a structured clinical interview for current psychiatric diagnosis according to Diagnostic Statistical Manual, fourth edition (DSM-IV) (MINI-Plus) and psychometric scales, including the Yale-Brown Obsessive-Compulsive Scale (YBOCS), the Beck Depression Inventory (BDI), the Hamilton Rating Scale for Depression (HRSD), the Hamilton Anxiety Scale (HAS) and the Liebowitz Social Anxiety Scale (LSAS).
RESULTS: BS and HS groups did not differ in most demographic and clinical parameters, such as gender, age and length of symptoms. The frequency of psychiatric disorders and the severity of psychiatric symptoms were similar in both groups.
CONCLUSION: BS does not seem to have more psychiatric disorders than HS.

Entities:  

Year:  2010        PMID: 26952832     DOI: 10.1111/j.1601-5215.2009.00436.x

Source DB:  PubMed          Journal:  Acta Neuropsychiatr        ISSN: 0924-2708            Impact factor:   3.403


  2 in total

1.  Psychiatric associations of adult-onset focal dystonia phenotypes.

Authors:  Brian D Berman; Johanna Junker; Erika Shelton; Stefan H Sillau; H A Jinnah; Joel S Perlmutter; Alberto J Espay; Joseph Jankovic; Marie Vidailhet; Cecilia Bonnet; William Ondo; Irene A Malaty; Ramón Rodríguez; William M McDonald; Laura Marsh; Mateusz Zurowski; Tobias Bäumer; Norbert Brüggemann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-04-24       Impact factor: 10.154

2.  Subjective assessment of effectiveness, quality of life, and psychological status of patients receiving botulinum toxin therapy for hemifacial spasm, blepharospasm, or cervical dystonia.

Authors:  Tetsuharu Kako; Kazuya Nokura; Hiroshi Kaneko; Hideo Izawa
Journal:  Fujita Med J       Date:  2020-07-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.